Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

624
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
624
Respiratory Volumes and Capacities I01:26

Respiratory Volumes and Capacities I

1.8K
Assessing the respiratory rate and rhythm for a complete minute is crucial for evaluating the breathing pattern. Even a minor increase in the patient's average respiratory rate, by as little as three to five breaths per minute, is an early and vital indicator of respiratory distress. Patients with a respiratory rate exceeding twenty-four breaths per minute require close monitoring to determine the physiological alterations. This careful observation is essential for prompt recognition and...
1.8K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Clinical Frailty Scale predicts inpatient mortality in older hospitalised patients with idiopathic Parkinson's disease.

The journal of the Royal College of Physicians of Edinburgh·2018
Same author

The modern surgeon and competency assessment: are the workplace-based assessments evidence-based?

World journal of surgery·2014
Same author

Determination of perchlorate in infant formula by isotope dilution ion chromatography/tandem mass spectrometry.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2011
Same author

Experiments on Prolonged Protein Feeding with Special Reference to the Thyroid Gland and the Osseous System.

Medico-chirurgical transactions·2010
Same author

REPORT XCVII. OBSERVATIONS ON THE PARATHYROIDS AND ACCESSORY THYROIDS IN MAN.

British medical journal·2010
Same author

REPORT CI. THE STRUCTURE AND SECRETION OF THE PARATHYROID GLANDS IN MAN.

British medical journal·2010
Same journal

Dr Archibald Hewan (1832-1883) and the University of Glasgow's medical libraries.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

Joyce Grainger Learning Centre.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

Features in this issue.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

An unusual case of cutaneous tuberculosis and paradoxical TB in a patient with spondyloarthritis treated with adalimumab.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

Leptospiral infection overlapping with autoimmune hepatitis: A diagnostic conundrum.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

Tocilizumab vs bevacizumab in critically ill COVID-19 patients: Registry-based prospective study.

The journal of the Royal College of Physicians of Edinburgh·2025
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K

Respiratory dysfunction in Parkinson's disease.

K M Torsney1, D Forsyth

  • 1D Forsyth, Department of Medicine for, the Elderly, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.

The Journal of the Royal College of Physicians of Edinburgh
|June 2, 2017
PubMed
Summary
This summary is machine-generated.

Parkinson's disease (PD) is linked to varied respiratory issues, from asymptomatic cases to severe breathing problems. Further research is needed to understand the causes and treatments for respiratory dysfunction in PD patients.

Keywords:
Parkinson’s diseasedyspnoeapulmonary function testsrespiratory dysfunction

More Related Videos

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

13.8K
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.2K

Related Experiment Videos

Last Updated: Mar 1, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K
Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

13.8K
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.2K

Area of Science:

  • Neurology
  • Pulmonology
  • Movement Disorders

Background:

  • Respiratory dysfunction has been recognized in Parkinson's disease (PD) since its initial description.
  • Observed respiratory symptoms in PD patients range from asymptomatic to severe, including shortness of breath and stridor.

Purpose of the Study:

  • To review and synthesize current literature on respiratory dysfunction in Parkinson's disease.
  • To identify key factors contributing to respiratory issues and areas requiring further investigation.

Main Methods:

  • An electronic literature search was performed using PubMed and Google Scholar in August 2016.
  • Included studies reported on respiratory dysfunction specifically associated with Parkinson's disease.

Main Results:

  • Respiratory dysfunction in PD stems from multiple factors: restrictive lung changes, upper airway obstruction, altered ventilatory control, and medication effects.
  • Significant debate exists regarding the precise mechanisms, prevalence, and impact of levodopa on respiration in PD.

Conclusions:

  • Larger, standardized studies are essential to elucidate the pathophysiology of respiratory dysfunction in Parkinson's disease.
  • Consistent methodology and patient stratification are needed for a clearer understanding of PD-related respiratory complications.